{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T06:50:50Z","timestamp":1793429450781,"version":"4.5.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-024-54909-4","type":"journal-article","created":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T06:35:15Z","timestamp":1733380515000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["A penta-component mpox mRNA vaccine induces protective immunity in nonhuman primates"],"prefix":"10.1038","volume":"15","author":[{"given":"Qing","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong-Rong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-Yao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Xu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Cong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5772-9482","authenticated-orcid":false,"given":"Lin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianrong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongzhi","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6263-1508","authenticated-orcid":false,"given":"Hai-Tao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8839-980X","authenticated-orcid":false,"given":"Chao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-Ting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng-Jian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiye","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye-Feng","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5963-1136","authenticated-orcid":false,"given":"Wen-Jie","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9113-2433","authenticated-orcid":false,"given":"Jing","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0632-2807","authenticated-orcid":false,"given":"Cheng-Feng","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,5]]},"reference":[{"key":"54909_CR1","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41577-022-00775-4","volume":"22","author":"FM Lum","year":"2022","unstructured":"Lum, F. M. et al. Monkeypox: disease epidemiology, host immunity and clinical interventions. Nat. Rev. Immunol. 22, 597\u2013613 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"54909_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/br.37.1.1-18.1973","volume":"37","author":"CT Cho","year":"1973","unstructured":"Cho, C. T. & Wenner, H. A. Monkeypox virus. Bacteriol. Rev. 37, 1\u201318 (1973).","journal-title":"Bacteriol. Rev."},{"key":"54909_CR3","doi-asserted-by":"publisher","first-page":"e0009222","DOI":"10.1128\/cmr.00092-22","volume":"35","author":"S Elsayed","year":"2022","unstructured":"Elsayed, S., Bondy, L. & Hanage, W. P. Monkeypox virus infections in humans. Clin. Microbiol. Rev. 35, e0009222 (2022).","journal-title":"Clin. Microbiol. Rev."},{"key":"54909_CR4","unstructured":"WHO. Multi-country monkeypox outbreak in non-endemic countries. https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/2022-DON385 (2022)."},{"key":"54909_CR5","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1016\/S0140-6736(22)01437-4","volume":"400","author":"C Wenham","year":"2022","unstructured":"Wenham, C. & Eccleston-Turner, M. Monkeypox as a PHEIC: implications for global health governance. Lancet 400, 2169\u20132171 (2022).","journal-title":"Lancet"},{"key":"54909_CR6","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1038\/s41591-022-01907-y","volume":"28","author":"J Isidro","year":"2022","unstructured":"Isidro, J. et al. Phylogenomic characterization and signs of microevolution in the 2022 multi-country outbreak of monkeypox virus. Nat. Med. 28, 1569\u20131572 (2022).","journal-title":"Nat. Med."},{"key":"54909_CR7","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1056\/NEJMe2210535","volume":"387","author":"HC Lane","year":"2022","unstructured":"Lane, H. C. & Fauci, A. S. Monkeypox - past as prologue. N. Engl. J. Med. 387, 749\u2013750 (2022).","journal-title":"N. Engl. J. Med."},{"key":"54909_CR8","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1056\/NEJMoa2207323","volume":"387","author":"JP Thornhill","year":"2022","unstructured":"Thornhill, J. P. et al. Monkeypox virus infection in humans across 16 countries - April-June 2022. N. Engl. J. Med. 387, 679\u2013691 (2022).","journal-title":"N. Engl. J. Med."},{"key":"54909_CR9","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/S0140-6736(22)01436-2","volume":"400","author":"EJ Tarin-Vicente","year":"2022","unstructured":"Tarin-Vicente, E. J. et al. Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain: a prospective observational cohort study. Lancet 400, 661\u2013669 (2022).","journal-title":"Lancet"},{"key":"54909_CR10","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1016\/S1473-3099(22)00411-X","volume":"22","author":"N Girometti","year":"2022","unstructured":"Girometti, N. et al. Demographic and clinical characteristics of confirmed human monkeypox virus cases in individuals attending a sexual health centre in London, UK: an observational analysis. Lancet Infect. Dis. 22, 1321\u20131328 (2022).","journal-title":"Lancet Infect. Dis."},{"key":"54909_CR11","doi-asserted-by":"publisher","first-page":"e072410","DOI":"10.1136\/bmj-2022-072410","volume":"378","author":"A Patel","year":"2022","unstructured":"Patel, A. et al. Clinical features and novel presentations of human monkeypox in a central London centre during the 2022 outbreak: descriptive case series. BMJ 378, e072410 (2022).","journal-title":"BMJ"},{"key":"54909_CR12","first-page":"2200772","volume":"28","author":"CE van Ewijk","year":"2023","unstructured":"van Ewijk, C. E. et al. Mpox outbreak in the Netherlands, 2022: public health response, characteristics of the first 1,000 cases and protection of the first-generation smallpox vaccine. Euro Surveill. 28, 2200772 (2023).","journal-title":"Euro Surveill."},{"key":"54909_CR13","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/S1473-3099(22)00354-1","volume":"22","author":"A Zumla","year":"2022","unstructured":"Zumla, A. et al. Monkeypox outbreaks outside endemic regions: scientific and social priorities. Lancet Infect. Dis. 22, 929\u2013931 (2022).","journal-title":"Lancet Infect. Dis."},{"key":"54909_CR14","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S0140-6736(23)00273-8","volume":"401","author":"O Mitja","year":"2023","unstructured":"Mitja, O. et al. Mpox in people with advanced HIV infection: a global case series. Lancet 401, 939\u2013949 (2023).","journal-title":"Lancet"},{"key":"54909_CR15","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/S0140-6736(22)02075-X","volume":"401","author":"O Mitja","year":"2023","unstructured":"Mitja, O. et al. Monkeypox. Lancet 401, 60\u201374 (2023).","journal-title":"Lancet"},{"key":"54909_CR16","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/S1473-3099(19)30294-4","volume":"19","author":"A Yinka-Ogunleye","year":"2019","unstructured":"Yinka-Ogunleye, A. et al. Outbreak of human monkeypox in Nigeria in 2017-18: a clinical and epidemiological report. Lancet Infect. Dis. 19, 872\u2013879 (2019).","journal-title":"Lancet Infect. Dis."},{"key":"54909_CR17","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.15585\/mmwr.mm7136a1","volume":"71","author":"KG Curran","year":"2022","unstructured":"Curran, K. G. et al. HIV and sexually transmitted infections among persons with monkeypox - eight U.S. Jurisdictions, May 17-July 22, 2022. MMWR Morb. Mortal. Wkly. Rep. 71, 1141\u20131147 (2022).","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"54909_CR18","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1097\/QAD.0000000000003495","volume":"37","author":"SL Heath","year":"2023","unstructured":"Heath, S. L. & Bansal, A. Mpox infection in people living with HIV. AIDS 37, 701\u2013703 (2023).","journal-title":"AIDS"},{"key":"54909_CR19","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/d41586-023-01581-1","volume":"617","author":"L Liverpool","year":"2023","unstructured":"Liverpool, L. The disease will be neglected\u2019: scientists react to the WHO ending mpox emergency. Nature 617, 662\u2013663 (2023).","journal-title":"Nature"},{"key":"54909_CR20","doi-asserted-by":"crossref","unstructured":"Vakaniaki, E. H. et al. Sustained human outbreak of a new MPXV clade I lineage in eastern Democratic Republic of the Congo. Nat. Med. 30, 2791\u20132795 (2024).","DOI":"10.1038\/s41591-024-03130-3"},{"key":"54909_CR21","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.cell.2016.09.049","volume":"167","author":"I Gilchuk","year":"2016","unstructured":"Gilchuk, I. et al. Cross-Neutralizing and Protective Human Antibody Specificities to Poxvirus Infections. Cell 167, 684\u2013694.e689 (2016).","journal-title":"Cell"},{"key":"54909_CR22","doi-asserted-by":"publisher","first-page":"4433","DOI":"10.1128\/JVI.78.9.4433-4443.2004","volume":"78","author":"JW Hooper","year":"2004","unstructured":"Hooper, J. W. et al. Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox. J. Virol. 78, 4433\u20134443 (2004).","journal-title":"J. Virol."},{"key":"54909_CR23","doi-asserted-by":"publisher","first-page":"10230","DOI":"10.1128\/JVI.78.19.10230-10237.2004","volume":"78","author":"C Fogg","year":"2004","unstructured":"Fogg, C. et al. Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions. J. Virol. 78, 10230\u201310237 (2004).","journal-title":"J. Virol."},{"key":"54909_CR24","doi-asserted-by":"publisher","first-page":"4590","DOI":"10.1073\/pnas.0401165101","volume":"101","author":"LS Wyatt","year":"2004","unstructured":"Wyatt, L. S., Earl, P. L., Eller, L. A. & Moss, B. Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge. Proc. Natl. Acad. Sci. USA 101, 4590\u20134595 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"54909_CR25","unstructured":"FDA. FDA approves first live, non-replicating vaccine to prevent smallpox and monkeypox. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-live-non-replicating-vaccine-prevent-smallpox-and-monkeypox (2019)."},{"key":"54909_CR26","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1517\/13543784.17.4.555","volume":"17","author":"RN Greenberg","year":"2008","unstructured":"Greenberg, R. N. & Kennedy, J. S. ACAM2000: a newly licensed cell culture-based live vaccinia smallpox vaccine. Expert Opin. Investig. Drugs 17, 555\u2013564 (2008).","journal-title":"Expert Opin. Investig. Drugs"},{"key":"54909_CR27","doi-asserted-by":"crossref","unstructured":"Zaeck, L. M. et al. Low levels of monkeypox virus-neutralizing antibodies after MVA-BN vaccination in healthy individuals. Nat. Med. 29, 270\u2013278 (2023).","DOI":"10.1038\/s41591-022-02090-w"},{"key":"54909_CR28","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2024.2306967","volume":"13","author":"L Tian","year":"2024","unstructured":"Tian, L. et al. Vaccinia virus tiantan strain is inefficient in eliciting cross-reactive immunity against the emerging monkeypox virus strain. Emerg. Microbes Infect. 13, 2306967 (2024).","journal-title":"Emerg. Microbes Infect."},{"key":"54909_CR29","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0042-6822(02)00038-7","volume":"306","author":"JW Hooper","year":"2003","unstructured":"Hooper, J. W., Custer, D. M. & Thompson, E. Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates. Virology 306, 181\u2013195 (2003).","journal-title":"Virology"},{"key":"54909_CR30","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1093\/infdis\/jiq017","volume":"203","author":"LA Hirao","year":"2011","unstructured":"Hirao, L. A. et al. Multivalent smallpox DNA vaccine delivered by intradermal electroporation drives protective immunity in nonhuman primates against lethal monkeypox challenge. J. Infect. Dis. 203, 95\u2013102 (2011).","journal-title":"J. Infect. Dis."},{"key":"54909_CR31","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01504-21","volume":"96","author":"EM Mucker","year":"2022","unstructured":"Mucker, E. M. et al. A nucleic acid-based orthopoxvirus vaccine targeting the vaccinia virus L1, A27, B5, and A33 proteins protects rabbits against lethal rabbitpox virus aerosol challenge. J. Virol. 96, e0150421 (2022).","journal-title":"J. Virol."},{"key":"54909_CR32","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adg3540","volume":"15","author":"AW Freyn","year":"2023","unstructured":"Freyn, A. W. et al. An mpox virus mRNA-lipid nanoparticle vaccine confers protection against lethal orthopoxviral challenge. Sci. Transl. Med. 15, eadg3540 (2023).","journal-title":"Sci. Transl. Med."},{"key":"54909_CR33","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2023.2192815","volume":"12","author":"RR Zhang","year":"2023","unstructured":"Zhang, R. R. et al. Rational development of multicomponent mRNA vaccine candidates against mpox. Emerg. Microbes Infect. 12, 2192815 (2023).","journal-title":"Emerg. Microbes Infect."},{"key":"54909_CR34","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/s41392-023-01432-5","volume":"8","author":"Y Sang","year":"2023","unstructured":"Sang, Y. et al. Monkeypox virus quadrivalent mRNA vaccine induces immune response and protects against vaccinia virus. Signal Transduct. Target. Ther. 8, 172 (2023).","journal-title":"Signal Transduct. Target. Ther."},{"key":"54909_CR35","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2023.2204151","volume":"12","author":"J Zeng","year":"2023","unstructured":"Zeng, J. et al. Mpox multi-antigen mRNA vaccine candidates by a simplified manufacturing strategy afford efficient protection against lethal orthopoxvirus challenge. Emerg. Microbes Infect. 12, 2204151 (2023).","journal-title":"Emerg. Microbes Infect."},{"key":"54909_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41628-5","volume":"14","author":"F Hou","year":"2023","unstructured":"Hou, F. et al. mRNA vaccines encoding fusion proteins of monkeypox virus antigens protect mice from vaccinia virus challenge. Nat. Commun. 14, 5925 (2023).","journal-title":"Nat. Commun."},{"key":"54909_CR37","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/s41422-023-00792-5","volume":"33","author":"Z Fang","year":"2023","unstructured":"Fang, Z. et al. Polyvalent mRNA vaccination elicited potent immune response to monkeypox virus surface antigens. Cell Res. 33, 407\u2013410 (2023).","journal-title":"Cell Res."},{"key":"54909_CR38","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.cell.2024.01.017","volume":"187","author":"A Zuiani","year":"2024","unstructured":"Zuiani, A. et al. A multivalent mRNA monkeypox virus vaccine (BNT166) protects mice and macaques from orthopoxvirus disease. Cell 187, 1363\u20131373.e12 (2024).","journal-title":"Cell"},{"key":"54909_CR39","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.virol.2006.07.017","volume":"355","author":"P Sakhatskyy","year":"2006","unstructured":"Sakhatskyy, P., Wang, S., Chou, T. H. & Lu, S. Immunogenicity and protection efficacy of monovalent and polyvalent poxvirus vaccines that include the D8 antigen. Virology 355, 164\u2013174 (2006).","journal-title":"Virology"},{"key":"54909_CR40","doi-asserted-by":"publisher","first-page":"12355","DOI":"10.1128\/JVI.01593-09","volume":"83","author":"MR Benhnia","year":"2009","unstructured":"Benhnia, M. R. et al. Heavily isotype-dependent protective activities of human antibodies against vaccinia virus extracellular virion antigen B5. J. Virol. 83, 12355\u201312367 (2009).","journal-title":"J. Virol."},{"key":"54909_CR41","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1128\/JVI.01797-08","volume":"83","author":"MR Benhnia","year":"2009","unstructured":"Benhnia, M. R. et al. Vaccinia virus extracellular enveloped virion neutralization in vitro and protection in vivo depend on complement. J Virol. 83, 1201\u20131215 (2009).","journal-title":"J Virol."},{"key":"54909_CR42","doi-asserted-by":"publisher","first-page":"e20597","DOI":"10.1371\/journal.pone.0020597","volume":"6","author":"ME Cohen","year":"2011","unstructured":"Cohen, M. E., Xiao, Y., Eisenberg, R. J., Cohen, G. H. & Isaacs, S. N. Antibody against extracellular vaccinia virus (EV) protects mice through complement and Fc receptors. PLoS ONE 6, e20597 (2011).","journal-title":"PLoS ONE"},{"key":"54909_CR43","doi-asserted-by":"publisher","first-page":"e1005148","DOI":"10.1371\/journal.ppat.1005148","volume":"11","author":"MH Matho","year":"2015","unstructured":"Matho, M. H. et al. Structural and functional characterization of anti-A33 antibodies reveal a potent cross-species orthopoxviruses neutralizer. PLoS Pathog. 11, e1005148 (2015).","journal-title":"PLoS Pathog."},{"key":"54909_CR44","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.cell.2020.07.024","volume":"182","author":"NN Zhang","year":"2020","unstructured":"Zhang, N. N. et al. A thermostable mRNA vaccine against COVID-19. Cell 182, 1271\u20131283.e1216 (2020).","journal-title":"Cell"},{"key":"54909_CR45","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/s41422-022-00626-w","volume":"32","author":"NN Zhang","year":"2022","unstructured":"Zhang, N. N. et al. Rapid development of an updated mRNA vaccine against the SARS-CoV-2 Omicron variant. Cell Res. 32, 401\u2013403 (2022).","journal-title":"Cell Res."},{"key":"54909_CR46","first-page":"853","volume":"4","author":"H Zhao","year":"2022","unstructured":"Zhao, H. et al. The first imported case of monkeypox in the Mainland of China - Chongqing Municipality, China, September 16, 2022. China CDC Wkly. 4, 853\u2013854 (2022).","journal-title":"China CDC Wkly."},{"key":"54909_CR47","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.46234\/ccdcw2022.206","volume":"4","author":"B Huang","year":"2022","unstructured":"Huang, B. et al. Isolation and characterization of monkeypox virus from the first case of monkeypox - Chongqing Municipality, China, 2022. China CDC Wkly. 4, 1019\u20131024 (2022).","journal-title":"China CDC Wkly."},{"key":"54909_CR48","doi-asserted-by":"publisher","first-page":"4652","DOI":"10.1016\/j.cell.2023.08.023","volume":"186","author":"M Aid","year":"2023","unstructured":"Aid, M. et al. Mpox infection protects against re-challenge in rhesus macaques. Cell 186, 4652\u20134661.e4613 (2023).","journal-title":"Cell"},{"key":"54909_CR49","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/nature02331","volume":"428","author":"PL Earl","year":"2004","unstructured":"Earl, P. L. et al. Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox. Nature 428, 182\u2013185 (2004).","journal-title":"Nature"},{"key":"54909_CR50","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/nature04295","volume":"439","author":"KJ Stittelaar","year":"2006","unstructured":"Stittelaar, K. J. et al. Antiviral treatment is more effective than smallpox vaccination upon lethal monkeypox virus infection. Nature 439, 745\u2013748 (2006).","journal-title":"Nature"},{"key":"54909_CR51","doi-asserted-by":"publisher","first-page":"10889","DOI":"10.1073\/pnas.0804985105","volume":"105","author":"PL Earl","year":"2008","unstructured":"Earl, P. L. et al. Rapid protection in a monkeypox model by a single injection of a replication-deficient vaccinia virus. Proc. Natl. Acad. Sci. USA 105, 10889\u201310894 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"54909_CR52","doi-asserted-by":"publisher","first-page":"4898","DOI":"10.1128\/JVI.02525-10","volume":"85","author":"AJ Goff","year":"2011","unstructured":"Goff, A. J. et al. A novel respiratory model of infection with monkeypox virus in cynomolgus macaques. J. Virol. 85, 4898\u20134909 (2011).","journal-title":"J. Virol."},{"key":"54909_CR53","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1128\/JVI.01931-10","volume":"85","author":"RF Johnson","year":"2011","unstructured":"Johnson, R. F. et al. Comparative analysis of monkeypox virus infection of cynomolgus macaques by the intravenous or intrabronchial inoculation route. J. Virol. 85, 2112\u20132125 (2011).","journal-title":"J. Virol."},{"key":"54909_CR54","doi-asserted-by":"publisher","first-page":"7805","DOI":"10.1128\/JVI.03481-12","volume":"87","author":"GJ Hatch","year":"2013","unstructured":"Hatch, G. J. et al. Assessment of the protective effect of Imvamune and Acam2000 vaccines against aerosolized monkeypox virus in cynomolgus macaques. J. Virol. 87, 7805\u20137815 (2013).","journal-title":"J. Virol."},{"key":"54909_CR55","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jcv.2014.12.001","volume":"63","author":"SC Johnston","year":"2015","unstructured":"Johnston, S. C. et al. Cytokine modulation correlates with severity of monkeypox disease in humans. J. Clin. Virol. 63, 42\u201345 (2015).","journal-title":"J. Clin. Virol."},{"key":"54909_CR56","doi-asserted-by":"publisher","first-page":"156560","DOI":"10.1016\/j.cyto.2024.156560","volume":"177","author":"GB da Silva","year":"2024","unstructured":"da Silva, G. B., de Carvalho Braga, G., Simoes, J. L. B., Kempka, A. P. & Bagatini, M. D. Cytokine storm in human monkeypox: a possible involvement of purinergic signaling. Cytokine 177, 156560 (2024).","journal-title":"Cytokine"},{"key":"54909_CR57","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1128\/JVI.00984-08","volume":"83","author":"H Wei","year":"2009","unstructured":"Wei, H. et al. Coadministration of cidofovir and smallpox vaccine reduced vaccination side effects but interfered with vaccine-elicited immune responses and immunity to monkeypox. J. Virol. 83, 1115\u20131125 (2009).","journal-title":"J. Virol."},{"key":"54909_CR58","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1128\/AAC.00021-09","volume":"53","author":"J Huggins","year":"2009","unstructured":"Huggins, J. et al. Nonhuman primates are protected from smallpox virus or monkeypox virus challenges by the antiviral drug ST-246. Antimicrob. Agents Chemother. 53, 2620\u20132625 (2009).","journal-title":"Antimicrob. Agents Chemother."},{"key":"54909_CR59","doi-asserted-by":"publisher","first-page":"9684","DOI":"10.1016\/j.vaccine.2011.09.135","volume":"29","author":"KL Denzler","year":"2011","unstructured":"Denzler, K. L. et al. Attenuated NYCBH vaccinia virus deleted for the E3L gene confers partial protection against lethal monkeypox virus disease in cynomolgus macaques. Vaccine 29, 9684\u20139690 (2011).","journal-title":"Vaccine"},{"key":"54909_CR60","doi-asserted-by":"publisher","first-page":"6627","DOI":"10.1016\/j.vaccine.2010.07.030","volume":"28","author":"GW Buchman","year":"2010","unstructured":"Buchman, G. W. et al. A protein-based smallpox vaccine protects non-human primates from a lethal monkeypox virus challenge. Vaccine 28, 6627\u20136636 (2010).","journal-title":"Vaccine"},{"key":"54909_CR61","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.vaccine.2009.09.133","volume":"28","author":"JW Hooper","year":"2009","unstructured":"Hooper, J. W. et al. Molecular smallpox vaccine delivered by alphavirus replicons elicits protective immunity in mice and non-human primates. Vaccine 28, 494\u2013511 (2009).","journal-title":"Vaccine"},{"key":"54909_CR62","doi-asserted-by":"crossref","unstructured":"Mucker, E. M. et al. Comparison of protection against mpox following mRNA or modified vaccinia Ankara vaccination in nonhuman primates. Cell 187, 5540\u20135553 (2024).","DOI":"10.1016\/j.cell.2024.08.043"},{"key":"54909_CR63","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1038\/s41564-022-01259-w","volume":"7","author":"J Liu","year":"2022","unstructured":"Liu, J. et al. Retrospective detection of monkeypox virus in the testes of nonhuman primate survivors. Nat. Microbiol. 7, 1980\u20131986 (2022).","journal-title":"Nat. Microbiol."},{"key":"54909_CR64","doi-asserted-by":"publisher","first-page":"4335","DOI":"10.1128\/JVI.03029-14","volume":"89","author":"JA Tree","year":"2015","unstructured":"Tree, J. A. et al. Sequence of pathogenic events in cynomolgus macaques infected with aerosolized monkeypox virus. J. Virol. 89, 4335\u20134344 (2015).","journal-title":"J. Virol."},{"key":"54909_CR65","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.meegid.2012.12.002","volume":"14","author":"KA Bratke","year":"2013","unstructured":"Bratke, K. A., McLysaght, A. & Rothenburg, S. A survey of host range genes in poxvirus genomes. Infect. Genet. Evol. 14, 406\u2013425 (2013).","journal-title":"Infect. Genet. Evol."},{"key":"54909_CR66","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/524743","volume":"2012","author":"SN Shchelkunov","year":"2012","unstructured":"Shchelkunov, S. N. Orthopoxvirus genes that mediate disease virulence and host tropism. Adv. Virol. 2012, 524743 (2012).","journal-title":"Adv. Virol."},{"key":"54909_CR67","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1126\/science.2237434","volume":"250","author":"GJ Kotwal","year":"1990","unstructured":"Kotwal, G. J., Isaacs, S. N., McKenzie, R., Frank, M. M. & Moss, B. Inhibition of the complement cascade by the major secretory protein of vaccinia virus. Science 250, 827\u2013830 (1990).","journal-title":"Science"},{"key":"54909_CR68","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1073\/pnas.89.2.628","volume":"89","author":"SN Isaacs","year":"1992","unstructured":"Isaacs, S. N., Kotwal, G. J. & Moss, B. Vaccinia virus complement-control protein prevents antibody-dependent complement-enhanced neutralization of infectivity and contributes to virulence. Proc. Natl. Acad. Sci. USA 89, 628\u2013632 (1992).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"54909_CR69","doi-asserted-by":"crossref","unstructured":"Gruner, E. et al. Mpox-specific immune responses elicited by vaccination or infection in people living with HIV. J. Infect. Dis. 230, 1110\u20131119 (2024).","DOI":"10.1093\/infdis\/jiae138"},{"key":"54909_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/QCO.0000000000000994","volume":"37","author":"I Maan","year":"2024","unstructured":"Maan, I., Kohli, M. & Gilson, R. Mpox in people living with HIV. Curr. Opin. Infect. Dis. 37, 1\u20137 (2024).","journal-title":"Curr. Opin. Infect. Dis."},{"key":"54909_CR71","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1016\/S0140-6736(23)01674-4","volume":"402","author":"M Wong","year":"2023","unstructured":"Wong, M., Damon, I. K., Zucker, J., Foote, M. M. K. & El-Sadr, W. ART initiation for people living with HIV with severe mpox. Lancet 402, 1750 (2023).","journal-title":"Lancet"},{"key":"54909_CR72","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1089\/aid.2023.0034","volume":"39","author":"MO Iroezindu","year":"2023","unstructured":"Iroezindu, M. O., Crowell, T. A., Ogoina, D. & Yinka-Ogunleye, A. Human Mpox in people living with HIV: epidemiologic and clinical perspectives from Nigeria. AIDS Res. Hum. Retroviruses 39, 593\u2013600 (2023).","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"54909_CR73","doi-asserted-by":"publisher","first-page":"e210","DOI":"10.1093\/cid\/ciaa143","volume":"71","author":"D Ogoina","year":"2020","unstructured":"Ogoina, D. et al. Clinical course and outcome of human monkeypox in Nigeria. Clin. Infect. Dis. 71, e210\u2013e214 (2020).","journal-title":"Clin. Infect. Dis."},{"key":"54909_CR74","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/S1473-3099(22)00228-6","volume":"22","author":"H Adler","year":"2022","unstructured":"Adler, H. et al. Clinical features and management of human monkeypox: a retrospective observational study in the UK. Lancet Infect. Dis. 22, 1153\u20131162 (2022).","journal-title":"Lancet Infect. Dis."},{"key":"54909_CR75","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.15585\/mmwr.mm7144e1","volume":"71","author":"MJ Miller","year":"2022","unstructured":"Miller, M. J. et al. Severe monkeypox in hospitalized patients - United States, August 10-October 10, 2022. MMWR Morb. Mortal. Wkly. Rep. 71, 1412\u20131417 (2022).","journal-title":"MMWR Morb. Mortal. Wkly. Rep"},{"key":"54909_CR76","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/nm1273","volume":"11","author":"E Hammarlund","year":"2005","unstructured":"Hammarlund, E. et al. Multiple diagnostic techniques identify previously vaccinated individuals with protective immunity against monkeypox. Nat. Med. 11, 1005\u20131011 (2005).","journal-title":"Nat. Med."},{"key":"54909_CR77","doi-asserted-by":"publisher","first-page":"e1007552","DOI":"10.1371\/journal.ppat.1007552","volume":"15","author":"H Chong","year":"2019","unstructured":"Chong, H. et al. Monotherapy with a low-dose lipopeptide HIV fusion inhibitor maintains long-term viral suppression in rhesus macaques. PLoS Pathog. 15, e1007552 (2019).","journal-title":"PLoS Pathog."},{"key":"54909_CR78","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.cell.2021.11.032","volume":"185","author":"J Xue","year":"2022","unstructured":"Xue, J. et al. Efficient treatment and pre-exposure prophylaxis in rhesus macaques by an HIV fusion-inhibitory lipopeptide. Cell 185, 131\u2013144.e118 (2022).","journal-title":"Cell"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54909-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54909-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54909-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T08:03:11Z","timestamp":1733385791000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54909-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,5]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["54909"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-54909-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4325129\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,5]]},"assertion":[{"value":"22 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.F.Q., Q.Y., R.R.Z., and Z.J.W. have filed a patent related to the vaccine reported in the study. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10611"}}